Avidity Partners Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,231,000
| Closed | -$146M | – | 102 |
|
|
2022
Q1 | $146M | Buy |
1,231,000
+91,000
| +8% | +$10.8M | 3.04% | 9 |
|
|
2021
Q4 | $157M | Buy |
1,140,000
+205,800
| +22% | +$28.4M | 3.33% | 6 |
|
|
2021
Q3 | $130M | Buy |
934,200
+51,700
| +6% | +$7.18M | 2.88% | 7 |
|
|
2021
Q2 | $85.7M | Sell |
882,500
-167,300
| -16% | -$16.2M | 2.32% | 10 |
|
|
2021
Q1 | $71.8M | Buy |
1,049,800
+558,000
| +113% | +$38.1M | 1.98% | 15 |
|
|
2020
Q4 | $42.2M | Sell |
491,800
-792,400
| -62% | -$67.9M | 1.37% | 22 |
|
|
2020
Q3 | $83.5M | Buy |
1,284,200
+179,700
| +16% | +$11.7M | 3.87% | 6 |
|
|
2020
Q2 | $80.8M | Buy |
1,104,500
+564,500
| +105% | +$41.3M | 5.18% | 3 |
|
|
2020
Q1 | $18.4M | Buy |
+540,000
| New | +$18.4M | 2.54% | 13 |
|